全文获取类型
收费全文 | 117488篇 |
免费 | 8315篇 |
国内免费 | 4861篇 |
专业分类
耳鼻咽喉 | 1033篇 |
儿科学 | 2136篇 |
妇产科学 | 1157篇 |
基础医学 | 16272篇 |
口腔科学 | 1216篇 |
临床医学 | 10997篇 |
内科学 | 27371篇 |
皮肤病学 | 1553篇 |
神经病学 | 4524篇 |
特种医学 | 2090篇 |
外国民族医学 | 9篇 |
外科学 | 7844篇 |
综合类 | 18312篇 |
现状与发展 | 19篇 |
一般理论 | 2篇 |
预防医学 | 10173篇 |
眼科学 | 652篇 |
药学 | 13361篇 |
60篇 | |
中国医学 | 7013篇 |
肿瘤学 | 4870篇 |
出版年
2024年 | 216篇 |
2023年 | 1509篇 |
2022年 | 3397篇 |
2021年 | 4286篇 |
2020年 | 3863篇 |
2019年 | 3924篇 |
2018年 | 3807篇 |
2017年 | 3752篇 |
2016年 | 4414篇 |
2015年 | 4674篇 |
2014年 | 8596篇 |
2013年 | 8562篇 |
2012年 | 8068篇 |
2011年 | 8652篇 |
2010年 | 6857篇 |
2009年 | 6331篇 |
2008年 | 6001篇 |
2007年 | 5921篇 |
2006年 | 5195篇 |
2005年 | 4387篇 |
2004年 | 3565篇 |
2003年 | 3053篇 |
2002年 | 2464篇 |
2001年 | 2209篇 |
2000年 | 1813篇 |
1999年 | 1651篇 |
1998年 | 1411篇 |
1997年 | 1186篇 |
1996年 | 990篇 |
1995年 | 1017篇 |
1994年 | 886篇 |
1993年 | 682篇 |
1992年 | 639篇 |
1991年 | 516篇 |
1990年 | 500篇 |
1989年 | 434篇 |
1988年 | 375篇 |
1987年 | 311篇 |
1986年 | 273篇 |
1985年 | 551篇 |
1984年 | 570篇 |
1983年 | 439篇 |
1982年 | 454篇 |
1981年 | 373篇 |
1980年 | 374篇 |
1979年 | 320篇 |
1978年 | 253篇 |
1977年 | 205篇 |
1976年 | 217篇 |
1975年 | 172篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
生物反馈技术治疗慢性盆底疼痛综合征及慢性前列腺炎 总被引:13,自引:0,他引:13
目的:评估生物反馈刺激治疗对慢性盆底疼痛综合征(CPPS)及慢性前列腺炎(CP)的效果。方法:评估30例患者治疗前后,前列腺液(EPS)及精液(SF)和临床症状的变化,包括每日排尿次数、尿急、疼痛和生活质量。使用侵入型的生物反馈刺激治疗仪,治疗周期5~15d,每次20min。结果:30例患者中的14例进行了5次生物反馈治疗,10例进行了10次,6例进行了15次治疗(平均每位患者治疗8.6次),追踪生物反馈治疗后0~2个月,并比较治疗前和治疗后的结果,显示病情有明显好转。结论:生物反馈刺激治疗对CP或CPPS患者能明显改善疼痛、尿频、尿急和生活质量,对CP患者能减少EPS或SF中的WBC。 相似文献
53.
Abstract End-stage liver disease caused by the hepatitis C virus is a major indication for liver transplantation. However, recurrence of hepatitis in the graft is a major issue. HCV re-infection after transplantation is almost constant, and recent data confirm that it significantly impairs patient and graft survival. Factors that may influence disease severity and consequent progression of HCV graft injury remain unclear. Chronic HCV infection develops in 60%–80% of patients, and 6%–28% ultimately progress to cirrhosis within 5 years. Pre-transplantation antiviral treatment is not easily related to poor tolerance. Attempts to administer prophylactic post-transplantation antiviral treatment are under evaluation but are limited by antiviral drug side effects. Treatment of established graft lesions with interferon or ribavirin as single agents has been disappointing. Combination therapy gave promising results, with sustained virological response in 25% of patients, but indications, modality and duration of treatment should be assessed. 相似文献
54.
55.
WHAN KOOK CHUNG KYU YONG CHOI CHANG DON LEE JIN WU CHUNG HEE SIK SUN KYU WON CHUNG BOO SUNG KIM CHUNG SIK CHUN KYOO HONG CHO SEUNG JO KIM 《Journal of gastroenterology and hepatology》1987,2(1):13-17
Different doses of hepatitis B virus vaccine—prepared by Korea Green Cross Corporation, were given to healthy infants born to HBsAg-negative mothers at birth, 1 and 6 months of age. A dose of 2 μg was administered intradermally in Group A and, in the three other groups, the vaccine was given intramuscularly (i.m.). An adequate follow-up observation was possible for 9 months after birth in 22, 25, 23 and 21 infants in Groups A, B, C and D, respecvely.
Group C (5 μg, i.m.) produced seroconversion most rapidly, showing the highest rate (96%) at 9 months of age. The lowest seroconversion rate (5%) was found at the age of 1 month in Group A subjects, but the rate increased to 91% after a booster dose was given at 6 months of age.
While it can be concluded that a 5 μg i.m. dose of vaccine at 0, 1 and 6 months of age is optimum for the immunization of infants in efficacy and economy, a 2 μg intradermal dose can also be considered as an immunogenic and economical regimen, though the immune response is slower and a special technique is required for immunization. 相似文献
Group C (5 μg, i.m.) produced seroconversion most rapidly, showing the highest rate (96%) at 9 months of age. The lowest seroconversion rate (5%) was found at the age of 1 month in Group A subjects, but the rate increased to 91% after a booster dose was given at 6 months of age.
While it can be concluded that a 5 μg i.m. dose of vaccine at 0, 1 and 6 months of age is optimum for the immunization of infants in efficacy and economy, a 2 μg intradermal dose can also be considered as an immunogenic and economical regimen, though the immune response is slower and a special technique is required for immunization. 相似文献
56.
分析了GELOGIQ 400B超机不能启动的故障,经对电源、主板、硬盘的维修,机器恢复正常。 相似文献
57.
58.
G Tufveson W Geelings M Broyer F P Brunner H Brynger S R Dykes J H Ehrich W Fassbinder G Rizzoni N H Selwood 《Nephrology, dialysis, transplantation》1989,4(3):161-171
This paper summarises the information given on the 1986 EDTA Registry centre questionnaire which was returned by 82% of the 2,065 known dialysis and transplant centres in 33 European countries. Information is given on the number of patients alive on haemodialysis according to the type of dialysis facilities available where the patient was receiving dialysis and the number of patients receiving special types of dialysis. The centre questionnaire also included questions on testing for HIV infection, serological evidence or symptoms of AIDS and the diagnosis of hepatitis B in patients and staff. The data given in response to these questions are presented together with data on the involvement of dietitians and social workers in the treatment of patients with end stage renal failure. Finally, information on transplant activity in Europe and the treatment policies of transplanting centres is provided. 相似文献
59.
Y. TRUDELLE A. BRACK A. DELMAS S. PEDOUSSAUT P. RIVAILLE 《Chemical biology & drug design》1987,30(1):54-60
Sequential poly(Arg-Thr-Lys-Pro) consisting mainly of the repeat of tuftsin Thr-Lys-Pro-Arg was synthesized by condensing the p-nitrophenyl ester of Arg(HCI)-Thr-Lys-(2-CI-Z)-Pro in the presence of HOBt . Two haptenic sequences of the Pre-S region of hepatitis B virus antigen (10–26 and 39–55) were prepared by solid phase and coupled to polytuftsin via glutaraldehyde. The peptides, either free or coupled to polytuftsin, were administrated to mice and the antisera were assayed by ELISA . Coupling the peptides to the polypeptide significantly improved the anti-peptide antibody titer in Freund complete adjuvant or in NaCI 0.9%. Cross-reaction between antibodies induced by the peptides and the native protein was also improved. Polytuftsin alone is very poorly immunogenic. 相似文献
60.
外源性核苷能抵消抗代谢药对肿瘤细胞的杀伤作用;核苷转运抑制剂潘生丁则能阻断核苷的这种抵消作用,从而增强抗代谢药的细胞毒性。本研究证明,胸苷和次黄嘌呤可明显抵消氨甲蝶呤对L1210细胞的杀伤作用,潘生丁则能有效地阻断核苷的抵消作用;潘生丁和两性霉素B合用可明显增强氨甲蝶呤对小鼠S180肉瘤的抑制作用,但不增强氨甲蝶呤对动物的毒性。提示潘生丁有可能应用于肿瘤联合化疗。 相似文献